The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-(3-(4-Amino-3-(1-methyl-5-morpholino-1H-pyrazol-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one ID: ALA4460560
PubChem CID: 141523781
Max Phase: Preclinical
Molecular Formula: C21H27N9O2
Molecular Weight: 437.51
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C=CC(=O)N1CCCC(n2nc(-c3cc(N4CCOCC4)n(C)n3)c3c(N)ncnc32)C1
Standard InChI: InChI=1S/C21H27N9O2/c1-3-17(31)29-6-4-5-14(12-29)30-21-18(20(22)23-13-24-21)19(26-30)15-11-16(27(2)25-15)28-7-9-32-10-8-28/h3,11,13-14H,1,4-10,12H2,2H3,(H2,22,23,24)
Standard InChI Key: OSPBHLWSQHFCKU-UHFFFAOYSA-N
Molfile:
RDKit 2D
32 36 0 0 0 0 0 0 0 0999 V2000
2.7473 -19.9345 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7462 -20.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4542 -21.1630 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.4524 -19.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1610 -19.9309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1659 -20.7540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9503 -21.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.4303 -20.3350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9424 -19.6720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4500 -18.7084 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1925 -18.8940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9682 -18.6369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9634 -17.8197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1846 -17.5717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7083 -18.2357 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9275 -16.7960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6240 -17.3384 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.3726 -17.6685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0291 -17.1880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9431 -16.3750 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1945 -16.0448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5320 -16.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2085 -21.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6631 -22.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9172 -23.1631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7170 -23.3326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2623 -22.7227 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0079 -21.9434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0621 -22.8907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3165 -23.6673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6074 -22.2821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1162 -23.8352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
4 10 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 1 0
15 11 2 0
9 11 1 0
14 16 1 0
17 18 1 0
17 22 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
13 17 1 0
23 24 1 0
23 28 1 0
24 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
7 23 1 0
27 29 1 0
29 30 1 0
29 31 2 0
30 32 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 437.51Molecular Weight (Monoisotopic): 437.2288AlogP: 1.00#Rotatable Bonds: 4Polar Surface Area: 120.22Molecular Species: NEUTRALHBA: 10HBD: 1#RO5 Violations: ┄HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 3.92CX LogP: 0.92CX LogD: 0.92Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.60Np Likeness Score: -1.13
References 1. Yin Y, Chen CJ, Yu RN, Shu L, Zhang TT, Zhang DY.. (2019) Discovery of novel selective Janus kinase 2 (JAK2) inhibitors bearing a 1H-pyrazolo[3,4-d]pyrimidin-4-amino scaffold., 27 (8): [PMID:30846405 ] [10.1016/j.bmc.2019.02.054 ]